Lexeo Therapeutics, Inc. (LXEO) Net income 2023–2026
Lexeo Therapeutics, Inc. (LXEO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$100.0MFY2026 · since FY2023: -$59.3M → -$100.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$100.0M | -1.7% |
| FY2025 | -$98.3M | -48.1% |
| FY2024 | -$66.4M | -12.0% |
| FY2023 | -$59.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LXEO financial trends
LXEO RevenueLXEO Net marginLXEO Gross profitLXEO Gross marginLXEO Operating incomeLXEO Operating marginLXEO Operating cash flowLXEO Free cash flowLXEO Capital expendituresLXEO Return on equityLXEO Stock buybacksLXEO Dividends paidLXEO Total assetsLXEO Total liabilitiesLXEO Shareholders’ equityLXEO overview →